Skip to main content

Oncternal Therapeutics, Inc.

ONCTDelisted Mar 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001260990

Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.

Q3 2025 vs. Q2 2025

How the institutions holding Oncternal Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of ONCT: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders110
Shares1751750 (0.0%)
Value$74$73−$1 (−1.4%)

New holders (0)

Institutions that held Oncternal Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

None.

Sold out (0)

Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

None.